Loading the section
MD Medical Group IPJSC (MDMG): the company is profitable, net margin 24.8%; profit is backed by cash, cash flow to profit 0.89×. Dividends are sustainable, yield 3.7%. The debt load is low, net debt / EBITDA −0.20×. Data as of 14 July 2026.
Answers to 4 of 4 questions
What share of revenue the company keeps as profit
Data as of 5 October 2026
Does the company pay dividends regularly and can it afford the payout
Data as of 14 July 2026
How large the company's debt is relative to its earnings
Data as of 5 October 2026
P/E · IFRS · Price as of 1 April 2026
Based on the 2025 annual report, P/E is 9.72×. In earlier years it ranged from 6.72× to 10.19×, with a median of 8.01×; observations: 5. That is above its own median.
By report year
P/E
Observations with a similar valuation: 4. The price was higher by the next annual report in this many cases: 2. The median price change was 5.9%, ranging from −17.3% to 40.3%.
A similar valuation means P/E within a quarter of the current value. Each year's price is taken the following spring, once the annual report is known; the price change runs between those dates of adjacent years and excludes dividends. The share count used is the current one. This describes the past and is not a forecast.
Dividends are sustainable, yield 3.7%. The last payout was RUB 47.00 per share.
The debt load is low, net debt / EBITDA −0.20×. Net debt is RUB −2.73 bn.
The company is profitable, net margin 24.8%. Net income is RUB 10.80 bn.
Based on the 2025 annual report, P/E is 9.72×. In earlier years it ranged from 6.72× to 10.19×, with a median of 8.01×; observations: 5. That is above its own median.
What date the figures on this page are as of
The analysis is built on the issuer's published financial statements and disclosures. It is information, not investment advice.
Is the company's profit backed by real cash
Data as of 5 October 2026
There is no forecast here: this page does not predict the price. It shows what happened after a similar valuation in the past. Observations with a similar valuation: 4. The price was higher by the next annual report in this many cases: 2. The median price change was 5.9%, ranging from −17.3% to 40.3%. A similar valuation means P/E within a quarter of the current value. Each year's price is taken the following spring, once the annual report is known; the price change runs between those dates of adjacent years and excludes dividends. The share count used is the current one. This describes the past and is not a forecast.